Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recent immunologic aspects].

M Pastural1, P Lang

  • 1Service de néphrologie, CHU Henri-Mondor, 51, avenue du Maréchal-de-Lattre- de-Tassigny, 94010 Créteil, France.

Annales D'Urologie
|January 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of the polymorph changes of a drug candidate.

Journal of pharmaceutical and biomedical analysis·2014
Same author

Radionecrosis of the frontal lobe as a consequence of malignant ethmoid tumor management: incidence, diagnosis, risk factors, prevention and management.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2014
Same author

Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

[Influence of anterior cruciate reconstruction on postural stability: A pre- and postoperative comparison].

Der Unfallchirurg·2014
Same author

Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD.

Bone marrow transplantation·2014
Same author

Long-range ordered nanodomains of grafted electroactive molecules.

The Journal of chemical physics·2013
Same journal

Prostate cancer at the 2007 ASCO meeting: an urologist's perspective.

Annales d'urologie·2008
Same journal

[Surgical treatment of ureteropyelic junction stenosis using robotic-assisted laparoscopy].

Annales d'urologie·2008
Same journal

[Robotic-assisted laparoscopy: general principles].

Annales d'urologie·2008
Same journal

[De novo tumours of renal transplants].

Annales d'urologie·2008
Same journal

[Immunosuppression in kidney transplantation].

Annales d'urologie·2008
Same journal

[Surgical complications in kidney transplantation].

Annales d'urologie·2008
See all related articles

Kidney transplant rejection involves hyperacute, acute, and chronic types. Advances in immunosuppressants reduce acute rejection, but research continues for chronic rejection and tolerance induction.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Science

Context:

  • Kidney transplantation is a vital treatment for end-stage renal disease.
  • Understanding graft rejection mechanisms is crucial for long-term transplant success.
  • Current challenges include managing highly sensitized recipients and chronic graft dysfunction.

Purpose:

  • To delineate the multifaceted nature of kidney transplant rejection.
  • To review the immunological pathways involved in hyperacute, acute, and chronic rejection.
  • To highlight advancements in immunosuppression and identify future research directions.

Summary:

  • Kidney graft rejection manifests as hyperacute (antibody-mediated), acute (T-cell initiated), and chronic (graft dysfunction).
  • While novel immunosuppressive drugs have significantly reduced acute rejection rates, chronic rejection and drug toxicity remain significant concerns.

Related Experiment Videos

  • Research is ongoing to address challenges in highly HLA-sensitized patients and chronic rejection, aiming for specific immune tolerance.

    • Impact:

    • Improved understanding of rejection pathways can inform clinical management strategies.
    • Advances in immunosuppression have led to better outcomes for acute rejection.
    • Future research focused on tolerance induction holds promise for overcoming chronic rejection and enhancing long-term graft survival.